Search Your Queries Related To Trilegal


Whether information disclosed in research/analyst reports amounts to UPSI?

22 Apr 2020

SEBI holds that information shared with investors through research/analyst reports may be relied upon by the investors as being generally available information (i.e. not UPSI), even before there is a specific disclosure/announcement about it by the company.

In recent orders passed by the Securities and Exchange Board of India (SEBI) regarding selective disclosure of unpublished price sensitive information (UPSI) by Manappuram Finance Ltd (MFL) in respect of: (i) Aditya Birla Sun Life AMC Limited; (ii) SBI Funds Management Private Limited; (iii) IDFC Asset Management Company Ltd; (iv) BNP Paribas Asset Management (I) P Ltd.; and (v) Kotak Mahindra Life Insurance Company Limited, SEBI considered the issue of whether trading by investors, based on analyst/research reports which contain UPSI, without knowing that such information is UPSI, would be considered insider trading. Leaning towards protecting the innocent investor in such cases, SEBI held that information shared with investors through research/analyst reports may be relied upon by such investors as being generally available information (i.e. not UPSI), even before specific disclosures/announcements are made by the company about it.

In this case, the analyst report contained a specific disclaimer that the recommendations in the report were based on publicly available information. However, in a situation where it could be shown that investors were aware that a report was based on UPSI, it is possible that SEBI would have investigated the role of the investors who would have traded based on such a report.

Besides recognizing that UPSI published in widely circulated analyst/research reports do not continue to remain ‘unpublished’, this order underlines the importance of investors paying close attention to the disclosed sources of information included in analyst reports and making sure there is no stated source of UPSI that forms the basis of their recommendations. Such an assessment would depend on the facts and circumstances of each case including:

  • Content and Disclaimer: The content of the analyst report will have to be assessed. In this case, the analyst report had a specific disclaimer which expressly stated that the recommendations in the report were based on publicly available information.
  • Meetings with company representatives: SEBI also held that mere references in the research report to meetings or calls with the representatives of the listed company are not sufficient to indicate to the reader that such information may be UPSI. Meetings between analysts and management of listed companies are a common practice in the industry before preparation of research reports. It is primarily a company’s duty not to divulge any UPSI during such meetings and the obligation of the research analyst not to publish research reports based on any UPSI.
  • Manner of dissemination and outreach: Further, it is relevant to consider the manner of dissemination (and outreach) of the UPSI upon its publication (prior to the trade). Disclosing the UPSI on stock exchanges by the listed company is only one of the ways in which UPSI may be validly disclosed. In this case, the research report containing UPSI about losses of MFL in a certain quarter had been circulated to 2194 email addresses by the research analyst, including media houses. Immediately after the circulation of the analyst report, the representatives of MFL held a conference call with the investors of MFL where the same UPSI was discussed and confirmed. Further, a news channel covered this on television (and referred to the analyst report and the conference call). Therefore, the information about losses of MFL in a certain quarter was not considered as UPSI at the time of the trades in this case.
  • Corroboration by other sources: Relying on its order in the case of 63 Moons Technologies dated 31 January 2018, SEBI noted that the coverage of the UPSI by the news channel was not speculative in nature since it was corroborated by the conference call and by information disclosed by MFL on the stock exchanges shortly after. Further, SEBI also noted that the corroboration of a research report by further similar research reports (by other research analysts) would also be relevant.

SEBI concluded that the UPSI had become public information since (i) the analyst report was circulated to over 2000 clients, including news platforms; (ii) a news channel extensively covered the same, before disclosure was made to the stock exchanges. Therefore, trades executed based on such information would not be considered insider trading.

Download PDF to read more

Subscribe to our Knowledge Repository

If you would like to receive content directly in your inbox from our knowledge repository, please complete this subscription form. This service is reserved for clients and eligible contacts.


    Under the rules of the Bar Council of India, Trilegal is prohibited from soliciting work or advertising in any form or manner. By accessing this website,, you acknowledge that:

    • You are seeking information about Trilegal of your own accord and there has been no form of solicitation, advertisement or inducement by Trilegal or its members.
    • This website should not be construed as providing legal advice for any purpose.
    • All information, content, and materials available on this website are for general informational purposes only.
    • Any information obtained or material downloaded from this website is completely at the user’s volition, and any transmission, receipt or use of this website is not intended to, and will not, create any lawyer-client relationship.
    • Information on this website may not constitute the most up-to-date legal or other information. Trilegal is not liable for the consequences of any action taken by any person based on any material or information available on this website, or for any inaccuracy in or exclusion of any information or interpretation thereof.
    • Readers of this website or recipients of content or information available on this website should not act based on any or all such content or information, and should always seek advice of competent legal counsel licensed to practice in the appropriate jurisdiction.
    • Third party links contained on this website re-directing users to such third-party websites should neither be construed as legal reference / legal advice, nor considered as referrals to, endorsements of, or affiliations with, any such third party website operators.
    • The communication platform provided on this website should not be used for exchange of any confidential, business or politically sensitive information.
    • The contents of this website are the intellectual property of Trilegal.

    We prioritize your privacy. Before proceeding, we encourage you to read our privacy policy, which outlines the below, and terms of use to understand how we handle your data:

    • The types of information we collect and why we collect them.
    • How we use your information to provide a personalized experience.
    • The measures we take to ensure the security of your data.
    • Your rights and choices in managing your personal information.
    • How we may share information with trusted partners for specific purpose.

    For more information, please read our terms of use and our privacy policy.

    Up arrow